WR9

N-[(3S)-5-amino-5-oxopent-1-en-3-yl]-1-{1-[4-(cyclopropylmethoxy)phenyl]cyclopropane-1-carbonyl}-L-prolinamide

Created:	2022-10-14
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where WR9 is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	62
Chiral Atom Count	2
Bond Count	65
Aromatic Bond Count	6

2D diagram of WR9

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-[(3S)-5-amino-5-oxopent-1-en-3-yl]-1-{1-[4-(cyclopropylmethoxy)phenyl]cyclopropane-1-carbonyl}-L-prolinamide
Systematic Name (OpenEye OEToolkits)	(2~{S})-~{N}-[(3~{S})-5-azanyl-5-oxidanylidene-pent-1-en-3-yl]-1-[1-[4-(cyclopropylmethoxy)phenyl]cyclopropyl]carbonyl-pyrrolidine-2-carboxamide
Formula	C₂₄ H₃₁ N₃ O₄
Molecular Weight	425.521
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(NC(C=C)CC(N)=O)C1CCCN1C(=O)C1(CC1)c1ccc(OCC2CC2)cc1
SMILES	CACTVS	3.385	NC(=O)C[CH](NC(=O)[CH]1CCCN1C(=O)C2(CC2)c3ccc(OCC4CC4)cc3)C=C
SMILES	OpenEye OEToolkits	2.0.7	C=CC(CC(=O)N)NC(=O)C1CCCN1C(=O)C2(CC2)c3ccc(cc3)OCC4CC4
Canonical SMILES	CACTVS	3.385	NC(=O)C[C@H](NC(=O)[C@H]1CCCN1C(=O)C2(CC2)c3ccc(OCC4CC4)cc3)C=C
Canonical SMILES	OpenEye OEToolkits	2.0.7	C=C[C@H](CC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)C2(CC2)c3ccc(cc3)OCC4CC4
InChI	InChI	1.06	InChI=1S/C24H31N3O4/c1-2-18(14-21(25)28)26-22(29)20-4-3-13-27(20)23(30)24(11-12-24)17-7-9-19(10-8-17)31-15-16-5-6-16/h2,7-10,16,18,20H,1,3-6,11-15H2,(H2,25,28)(H,26,29)/t18-,20+/m1/s1
InChIKey	InChI	1.06	SOCJRKDNYUYZLL-QUCCMNQESA-N

Related Resource References

Resource Name	Reference
PubChem	168654894

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.